SATURDAY, NOVEMBER 9, 2013

2:00-3:00
Validation of Preclinical Disease Models for Schizophrenia
Antti Nurmi

4:00-5:00
Stabilized Neuropeptides in the SOD1 Mouse Model of ALS
Outi Kontkanen

SUNDAY, NOVEMBER 10, 2013

8:00-9:00
Nuclear Imaging Characterization of G93A-SOD1 Mouse Model of Amyotrophic Lateral Sclerosis
Toni Ahtoniemi

9:00-10:00
Evaluation of Fine Motor Skill Impairment in the G93A-SOD1 Transgenic Mouse Model of Amyotrophic Lateral Sclerosis
Patrick Sweeney

9:00-10:00
Targeted Over-Expression with AAV-Mediated Human α-Synuclein in a Rat Model of Parkinson’s Disease - Validation of Novel Fine Motor Functional Effects as well as Neurochemical and Neuropathological Changes Over Time
Antti Nurmi

10:00-11:00
Longitudinal Characterization of CVN Mouse for Alzheimer's Disease Using Behavioral, Imaging and Biomarker Endpoints
Nina Vartiainen

MONDAY, NOVEMBER 11, 2013

10:00-11:00
Evaluation of Fine Motor Skill Impairment of R6/2 and zQ175 Knock-in Mice and BAC Rats of Huntington's Disease
Antti Nurmi

11:00-12:00
Longitudinal Anatomical, Metabolic and Functional Changes by MRI/MRS and PET and SPECT in zQ175 Knock-in Mouse Model of Huntington's Disease
Outi Kontkanen

4:00-5:00
Differential Distribution of G-CSF Transduced Human Mesenchymal Stem Cells in Stroke
Antti Nurmi

4:00-5:00
The Dichotomy and Polar Opposites Observed Between the Experimental Acute Encephalitis Murine Model and Human Secondary Progressive Multiple Sclerosis: Insight into Their Respective Pathogeneses via a Neuropeptide-Mediated Mechanism
Toni Ahtoniemi & Christopher Moore

TUESDAY, NOVEMBER 12, 2013

9:00-10:00
Impaired Thermoregulatory Capacity in R6/2 and xQ175 Mouse Models of Huntington's Disease during Cold Challenge
Outi Kontkanen

10:00-11:00
Immunohistochemical Characterization of R6/2 Transgenic and zQ175 Knock-in Mouse Models of Huntington's Disease
Nina Vartiainen

4:00-5:00
Dysferlin-Deficient Mice Show Muscle Dystrophy by MRI and Deficiency in Energy Metabolism
Toni Ahtoniemi

TUESDAY, NOVEMBER 13, 2013

9:00-10:00
Hyperimmune Caprine Serum - A Multi-Focal Therapeutic Strategy in Early- and Late-Stage Alzheimer's Disease
Toni Ahtoniemi